Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2002
10/24/2002US20020155122 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
10/24/2002US20020155121 Virus coat protein/receptor chimeras and methods of use
10/24/2002US20020155115 Cancer therapy
10/24/2002US20020155111 For the vaccination of patients having malignant B cell diseases
10/24/2002US20020155100 Compositions and methods for regulated protein expression in gut
10/24/2002US20020155096 Mixing stem cell preparation with a physiologically acceptable matrix material to form a stem cell matrix; incubating the stem-cell matrix in vitro prior to use in tissue or organ treatment or repair
10/24/2002DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
10/24/2002CA2447683A1 Dense/porous structures for use as bone substitutes
10/24/2002CA2445990A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002CA2444632A1 Vascular endothelial growth factor 2
10/24/2002CA2444624A1 Vascular endothelial growth factor 2
10/24/2002CA2444482A1 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
10/24/2002CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002CA2444164A1 Pufa polyketide synthase systems and uses thereof
10/24/2002CA2444133A1 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002CA2444047A1 Methods to inhibit viral replication
10/24/2002CA2444026A1 Mutants of desoxycytidine kinase having extended enzymatic activity
10/24/2002CA2444004A1 Method for autologous transplantation
10/24/2002CA2443995A1 Endothelial cell expression patterns
10/24/2002CA2443993A1 Methods and reagents for cell transplantation
10/24/2002CA2443984A1 Encapsulated cell indicator system
10/24/2002CA2443968A1 Diagnosis and treatment of cancer: i
10/24/2002CA2443903A1 Antibodies to vla-1
10/24/2002CA2443897A1 Transporters and ion channels
10/24/2002CA2443874A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002CA2443705A1 Cyclic single strand trispecific antibody
10/24/2002CA2443525A1 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections
10/24/2002CA2443493A1 Surface proteins of streptococcus pyogenes
10/24/2002CA2443408A1 Kinases and phosphatases
10/24/2002CA2443244A1 Enzymes
10/24/2002CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002CA2443088A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002CA2442819A1 Elimination of endogenous porcine retrovirus
10/24/2002CA2442729A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002CA2441699A1 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002CA2440846A1 Protein cluster v
10/24/2002CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/23/2002EP1251181A1 Non-recombinant cell lines capable of expressing predominantly cyclic nucleotide phosphodiesterase 4 (PDE4) subtype B and their use for the screening of PDE4 subtype-specific modulators
10/23/2002EP1251177A2 Cytokine-, stress-, and oncoprotein-activited human protein kinase kinases
10/23/2002EP1251176A2 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
10/23/2002EP1251170A2 Method and reagent for treatment of NF-kappaB dependent animal diseases
10/23/2002EP1251166A1 Method for selecting spermatozoon
10/23/2002EP1251139A2 Human mindin-like protein and nucleic acids encoding it
10/23/2002EP1250599A2 System for the internal qualitative and quantitative validation of marker indices
10/23/2002EP1250597A2 Identification of peripheral benzodiazepine receptor binding agents
10/23/2002EP1250594A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof
10/23/2002EP1250455A1 Antisense inhibition of ptp1b expression
10/23/2002EP1250453A1 Use of multiple recombination sites with unique specificity in recombinational cloning
10/23/2002EP1250447A2 Methods, media and apparatus for the introduction of molecules into plant cells and bacteria using aerosol beams
10/23/2002EP1250444A1 Methods for producing a polypeptide using a consensus translational initiator sequence
10/23/2002EP1250443A2 ANTI-CD3 SINGLE-CHAIN ANTIBODIES HAVING HUMAN C $g(m)?3 AND C $g(m)?4 DOMAINS
10/23/2002EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002EP1250432A2 Nuclear hormone receptors
10/23/2002EP1250429A2 Human sperm specific lysozyme-like proteins
10/23/2002EP1250425A2 Secreted human proteins, polynucleotides encoding them and methods of using the same
10/23/2002EP1250421A1 Recombinant flaviviruses and methods of use thereof
10/23/2002EP1250420A2 Techniques for growth and differentiation of human pluripotent stem cells
10/23/2002EP1250416A2 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue
10/23/2002EP1250352A1 Receptor-like protein kinases from nicotiana tabacum
10/23/2002EP1250349A2 Cardiac-cell specific enhancer elements and uses thereof
10/23/2002EP1250154A2 G-csf conjugates
10/23/2002EP1250109A1 Tissue graft
10/23/2002EP1250055A1 Immune modulation with death receptor-induced apoptosis
10/23/2002EP1250041A2 Storage of cells, tissues and organs in gel-based media
10/23/2002EP1250039A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor
10/23/2002EP1063891A4 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
10/23/2002EP1056336A4 Selection of mature sperm by surface membrane determinants
10/23/2002EP0948255A4 Improved chondrogenic differentiation of human mesenchymal stem cells
10/23/2002EP0909278A4 Nephropathy-related immunoglobulin g and antibodies for same
10/23/2002EP0883681B1 Conjugated linoleic acids for attenuating the allergic response
10/23/2002EP0880594B1 Retroviral vector and its use in gene therapy
10/23/2002EP0842262B1 Reversible membrane insert for growing tissue cultures
10/23/2002EP0766745B1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/23/2002EP0576623B1 Binding domains in notch and delta proteins
10/23/2002CN1376204A Flex seed specific promoters
10/23/2002CN1376201A Immunologically significant herpes simplex virus antigens
10/23/2002CN1376198A Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata
10/23/2002CN1376196A Method for generating immune-compatible cells and tissues using nuclear transfer techniques
10/23/2002CN1376163A Highly purified cytokine activating factor and methods of use
10/23/2002CN1376162A Novel techykinin peptides, precursor peptides thereof and genes encoding the same
10/23/2002CN1376073A Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation
10/23/2002CN1376067A Conditioned cell culture medium compositions and method of use
10/23/2002CN1375554A Method of obtaining mammary gland epithelial cell from mammary gland tissue of mammal
10/23/2002CN1375500A Thymic peptide fusion protein as one new interferon and its prepn. and use
10/23/2002CN1375190A One-step method for producing micro-budlet through tee leaves
10/22/2002US6469231 Starch branching enzyme II of potato
10/22/2002US6469230 Starch debranching enzymes
10/22/2002US6469155 HIgR and related domain which binds glycoprotein D of herpes simplex virus
10/22/2002US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002US6469142 Components of nmda receptors that have cation-selective channels and bind glutamate and nmda (n-methyl-d-aspartate)
10/22/2002US6469140 Molecules of the card-related protein family and uses thereof
10/22/2002US6468985 Administering nucleic acid molecule encoding retinoblastoma protein-interacting zinc finger protein at or adjacent to site of tumor, wherein protein comprises specified amino acid sequence and is expressed in tumor cell and reduces its growth
10/22/2002US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002US6468794 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
10/22/2002US6468791 Chromosone 1 gene and gene products related to Alzheimer's disease
10/22/2002US6468790 Metastatic breast and colon cancer regulated genes
10/22/2002US6468777 Through enhanced control and stabilization of protein production via stress proteins and the resultant protein products
10/22/2002US6468775 From a thermophilic eubacterium; polymerase shows magnesium ion dependent reverse transcriptase activity and 3'-5' exonuclease activity